J.‐L. PEGLION

732 total citations
17 papers, 627 citations indexed

About

J.‐L. PEGLION is a scholar working on Organic Chemistry, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, J.‐L. PEGLION has authored 17 papers receiving a total of 627 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Organic Chemistry, 7 papers in Molecular Biology and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in J.‐L. PEGLION's work include Receptor Mechanisms and Signaling (7 papers), Analytical Chemistry and Chromatography (2 papers) and Neuroscience and Neuropharmacology Research (2 papers). J.‐L. PEGLION is often cited by papers focused on Receptor Mechanisms and Signaling (7 papers), Analytical Chemistry and Chromatography (2 papers) and Neuroscience and Neuropharmacology Research (2 papers). J.‐L. PEGLION collaborates with scholars based in France. J.‐L. PEGLION's co-authors include Joël Vian, Alain P. Gobert, Jean‐Michel Rivet, M J Millan, Jean‐François Prost, Catherine Thollon, Adrian Newman‐Tancredi, J.-P. Vilaine, F. Lejeune and Valérie Audinot and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and The Journal of Organic Chemistry.

In The Last Decade

J.‐L. PEGLION

16 papers receiving 600 citations

Peers

Countries citing papers authored by J.‐L. PEGLION

Since Specialization

Citations

This map shows the geographic impact of J.‐L. PEGLION's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.‐L. PEGLION with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.‐L. PEGLION more than expected).

Fields of papers citing papers by J.‐L. PEGLION

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.‐L. PEGLION. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.‐L. PEGLION. The network helps show where J.‐L. PEGLION may publish in the future.

Co-authorship network of co-authors of J.‐L. PEGLION

This figure shows the co-authorship network connecting the top 25 collaborators of J.‐L. PEGLION. A scholar is included among the top collaborators of J.‐L. PEGLION based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.‐L. PEGLION. J.‐L. PEGLION is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Short Synthesis of the Selective Rho-Kinase Inhibitor Y-27632 and of Its Enantiomer 2005 ·Letters in Organic Chemistry ·Damien Belotti, J.‐L. PEGLION, Janine Cossy	1
2	S33005, a Novel Ligand at Both Serotonin and Norepinephrine Transporters: I. Receptor Binding, Electrophysiological, and Neurochemical Profile in Comparison with Venlafaxine, Reboxetine, Citalopram, and Clomipramine 2001 ·Journal of Pharmacology and Experimental Therapeutics ·M J Millan, Alain P. Gobert, F. Lejeune, Adrian Newman‐Tancredi, Jean‐Michel Rivet, Audrey Auclair, J.‐L. PEGLION	127
3	S18327 (1-[2-[4-(6-fluoro-1, 2-benzisoxazol-3-yl)piperid-1-yl]ethyl]3-phenyl imidazolin-2-one), a novel, potential antipsychotic displaying marked antagonist properties at alpha(1)- and alpha(2)-adrenergic receptors: I. Receptorial, neurochemical, and electrophysiological profile. 2000 ·PubMed ·Mark J. Millan, Alain P. Gobert, Adrian Newman‐Tancredi, F. Lejeune, Didier Cussac, Jean‐Michel Rivet, Valérie Audinot, (unknown), Mauricette Brocco, Jean‐Paul Nicolas, Jean A. Boutin, (unknown), J.‐L. PEGLION	13
4	ChemInform Abstract: Synthesis of Spiro[benzazepine‐2,4′‐piperidine]. 1998 ·ChemInform ·Janine Cossy, (unknown), Domingo Gomez Pardo, J.‐L. PEGLION, (unknown)	1
5	Synthesis of Spiro[benzazepine-2,4‘-piperidine] 1998 ·The Journal of Organic Chemistry ·Janine Cossy, (unknown), Domingo Gomez Pardo, J.‐L. PEGLION, (unknown)	13
6	An Easy and Efficient Access to 2-Bromo-4-methoxyaniline 1997 ·Synthetic Communications ·Janine Cossy, (unknown), Domingo Gomez Pardo, J.‐L. PEGLION	8
7	Stereochemical Study of a Bradicardisant Benzazepine-Type Drug. X-Ray Structure of the Chloride Salt and High-Field NMR Study of the Stereochemistry in Solution 1997 ·Magnetic Resonance in Chemistry ·(unknown), Philippe Hennig, (unknown), Joël Vian, J.‐L. PEGLION, (unknown), N. Platzer, Jean Guilhem	9
8	Stereochemical Study of a Bradicardisant BenzazepineType Drug. XRay Structure of the Chloride Salt and HighField NMR Study of the Stereochemistry in Solution 1997 ·Magnetic Resonance in Chemistry ·(unknown), Philippe Hennig, (unknown), Joël Vian, J.‐L. PEGLION, (unknown), N. Platzer, Jean Guilhem	2
9	ChemInform Abstract: Characterization of Potent and Selective Antagonists at Postsynaptic 5‐ HT1A Receptors in a Series of N4‐Substituted Arylpiperazines. 1996 ·ChemInform ·J.‐L. PEGLION, Hervé Canton, K Bervoets, Valérie Audinot, Mauricette Brocco, Alain P. Gobert, (unknown), Mark J. Millan	1
10	[3H](+)S 14297: A novel, selective radioligand at cloned human dopamine D3 receptors 1995 ·Neuropharmacology ·Adrian Newman‐Tancredi, Valérie Audinot, Vincent Jacques, J.‐L. PEGLION, Mark J. Millan	9
11	Characterization of Potent and Selective Antagonists at Postsynaptic 5-HT1A Receptors in a Series of N4-Substituted Arylpiperazines 1995 ·Journal of Medicinal Chemistry ·J.‐L. PEGLION, Hervé Canton, K Bervoets, Valérie Audinot, Mauricette Brocco, Alain P. Gobert, (unknown), Mark J. Millan	29
12	Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: 1. Activation of postsynaptic D3 receptors mediates hypothermia, whereas blockade of D2 receptors elicits prolactin secretion and catalepsy. 1995 ·Journal of Pharmacology and Experimental Therapeutics ·M J Millan, J.‐L. PEGLION, Joël Vian, Jean‐Michel Rivet, Mauricette Brocco, Alain P. Gobert, Adrian Newman‐Tancredi, Catherine Dacquet, K Bervoets, Sylvie Girardon	110
13	Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: II. Both D2 and "silent" D3 autoreceptors control synthesis and release in mesolimbic, mesocortical and nigrostriatal pathways. 1995 ·Journal of Pharmacology and Experimental Therapeutics ·Alain P. Gobert, Jean‐Michel Rivet, Valérie Audinot, Laetitia Cistarelli, Michael Spedding, Joël Vian, J.‐L. PEGLION, M J Millan	99
14	Structure of the intermediate formed in the synthesis of symmetrical pyrylium ions 1995 ·Journal of Physical Organic Chemistry ·M.‐C. Gazeau, (unknown), P. Valat, V. Wintgens, J. Kossanyi, D. Doizi, (unknown), (unknown), Bruno Perly, Joël Vian, J.‐L. PEGLION	0
15	Synthesis of 2-(Alkylamino)benzonitriles from α-(Bromoarylamino)nitriles 1995 ·Synthesis ·Janine Cossy, (unknown), Domingo Gomez Pardo, J.‐L. PEGLION	13
16	Electrophysiological effects of S 16257, a novel sino‐atrial node modulator, on rabbit and guinea‐pig cardiac preparations: comparison with UL‐FS 49 1994 ·British Journal of Pharmacology ·Catherine Thollon, (unknown), Joël Vian, Jean‐François Prost, J.‐L. PEGLION, J.-P. Vilaine	191
17	ChemInform Abstract: SYNTHESIS OF PERFLUOROALKYLPYRAZOLES: IDENTIFICATION BY FLUORINE‐19 NMR AND COMPARISON WITH HYDROCARBON HOMOLOGS 1980 ·Chemischer Informationsdienst ·J.‐L. PEGLION, Richard Pastor, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact